Jennifer Good
Founder bei TREVI THERAPEUTICS, INC.
Vermögen: 729 392 $ am 31.03.2024
Profil
Ms. Jennifer L.
Good, CPA, is an Independent Director at Rhythm Pharmaceuticals, Inc., a President, Chief Executive Officer & Director at Trevi Therapeutics, Inc. and a Treasurer at Newtown Youth & Family Services.
She is on the Board of Directors at Rhythm Pharmaceuticals, Inc., Trevi Therapeutics, Inc. and The Friedreich's Ataxia Research Alliance.
Ms. Good was previously employed as a President & Chief Executive Officer by Penwest Pharmaceuticals Co., a Controller by Penwest Ltd., and an Audit Manager by Ernst & Young LLP.
She also served on the board at Juniper Pharmaceuticals, Inc. and XTL Biopharmaceuticals Ltd.
She received her undergraduate degree from Pacific Lutheran University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TREVI THERAPEUTICS, INC.
0,31% | 15.02.2024 | 211 418 ( 0,31% ) | 729 392 $ | 31.03.2024 |
| 21.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Jennifer Good
| Unternehmen | Position | Beginn |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Founder | 01.03.2011 |
| RHYTHM PHARMACEUTICALS, INC. | Director/Board Member | 19.06.2019 |
The Friedreich's Ataxia Research Alliance
 The Friedreich's Ataxia Research Alliance Information Technology ServicesTechnology Services The Friedreich's Ataxia Research Alliance provides patient registry services. The private company is based in Downingtown, PA. | Director/Board Member | 01.01.2011 |
Ehemalige bekannte Positionen von Jennifer Good
| Unternehmen | Position | Ende |
|---|---|---|
| JUNIPER PHARMACEUTICALS INC | Director/Board Member | 14.08.2018 |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Chief Executive Officer | 01.12.2010 |
| PENFORD CORPORATION | Comptroller/Controller/Auditor | 01.01.1997 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.01.1993 |
| XTL BIOPHARMACEUTICALS LTD. | Director/Board Member | - |
Ausbildung von Jennifer Good
| Pacific Lutheran University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| XTL BIOPHARMACEUTICALS LTD. | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Pharmaceuticals: MajorHealth Technology Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets. The company was founded in December 1986 and is headquartered in Somerset, NJ. | Health Technology |
Penford Corp.
 Penford Corp. Agricultural Commodities/MillingProcess Industries Penford Corp. develops, manufactures and markets naturally based ingredient systems for various applications, including papermaking, textiles, food, pet and animal products, and fuel grade ethanol. The firm operates through two business segments: Industrial Ingredients and Food Ingredients. The Industrial Ingredients segment is a supplier of chemically modified specialty starches to the paper and packaging industries. The company was founded in September 1983 and is headquartered in Centennial, CO. | Process Industries |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
| Trevi Therapeutics, Inc. | |
The Friedreich's Ataxia Research Alliance
The Friedreich's Ataxia Research Alliance Information Technology ServicesTechnology Services The Friedreich's Ataxia Research Alliance provides patient registry services. The private company is based in Downingtown, PA. | Technology Services |
